SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 9.760-1.3%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tktrimbath6/30/2007 11:41:58 AM
Read Replies (1) of 557
 
6 month revisit to TGEN (Market cap ~ $0.035B)

INTRO Here's my semi-annual exercise to see if I remember why I own the stocks I own, and so I can check back and see if their stories have changed. I post in case it helps others too.

Targeted Genetics may have significant treatments for AIDs and arthritis. Someone else is paying for the AIDs treatment research and testing. Targeted is getting good, though not stellar results from their arthritis treatment clinical trials. They continue to struggle on from financing to financing, and may yet succeed to world-wide acclaim. Their success is still years away though. I've reduced my position for tax reasons, but will hold and watch because if they do succeed their rise will be significant.

DISCLAIMER LTBH since 2000 though the oldest shares are from 2001.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext